XTX Topco Ltd

Position in ESPR — Esperion Therapeutics, Inc.

CIK 1828301 LONDON, X0

Position in ESPR

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

+$0 QoQ

Shares Held

462,386

+115.8% QoQ

Ownership

0.180%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2022

11 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

XTX Topco Ltd holds $78,752,334 across 60 Drug Manufacturers - Specialty & Generic names. ESPR ranks #60 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ZTS	Zoetis Inc.	193,067	$13,873,794
2	VTRS	Viatris Inc	630,996	$10,020,216
3	UTHR	UNITED THERAPEUTICS Corp	13,055	$7,073,590
4	ELAN	Elanco Animal Health Inc	204,521	$5,033,261
5	NBIX	Neurocrine Biosciences Inc	27,124	$4,571,478
6	HIMS	Hims & Hers Health, Inc.	117,664	$4,079,410
7	PRGO	PERRIGO Co plc	275,509	$2,862,538
8	ALKS	Alkermes plc.	50,788	$2,661,291

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	—	462,386	+115.8%	Shares	Defined	2026-08-14
2026-03-31	—	214,231	+32.3%	Shares	Defined	2026-05-15
2025-12-31	—	161,974	+561.3%	Shares	Defined	2026-02-17
2024-12-31	—	24,494	-84.3%	Shares	Defined	2025-02-13
2024-09-30	—	156,300	-57.1%	Shares	Defined	2024-11-14
2024-06-30	—	364,681	+751.6%	Shares	Defined	2024-08-12
2024-03-31	—	42,822	-91.8%	Shares	Defined	2024-05-13
2023-09-30	—	519,129	+24.6%	Shares	Defined	2023-11-13
2023-06-30	—	416,752	+34.5%	Shares	Defined	2023-08-14
2023-03-31	—	309,781	+1557.8%	Shares	Defined	2023-05-12
2022-03-31	—	18,686	—	Shares	Defined	2022-05-13
No filing history on record for this holder in this stock.